Literature DB >> 6630785

Intracoronary nifedipine in human beings: magnitude and time course of changes in left ventricular contraction/relaxation and coronary sinus blood flow.

I Amende, R Simon, W P Hood, R Hetzer, P R Lichtlen.   

Abstract

Eight patients, all men, having at least 75% stenosis of the proximal, middle or both segments of the left anterior descending coronary artery, underwent intracoronary drug studies at the time of cardiac catheterization after saphenous vein bypass grafting. Nifedipine, 0.1 mg dissolved in saline solution, was infused into a left anterior descending graft that was the primary blood supply to each patient's anterior left ventricular wall and septum. High fidelity left ventricular pressure and its first derivative, dP/dt, and aortic pressure were sampled synchronously with coronary sinus blood flow by the thermodilution technique. The time constant of isovolumic pressure decay (T) was derived. In five patients, percent systolic shortening and mean shortening velocity were determined from myocardial markers implanted into the midwall of the myocardium at the time of cardiac surgery. In response to nifedipine, left ventricular systolic pressure decreased and end-diastolic pressure increased up to 60 seconds. Both positive and negative dP/dt also decreased up to 60 seconds, whereas coronary sinus blood flow increased up to 5 minutes. T was increased at 1 minute but returned to baseline by 3 minutes. Percent systolic shortening and mean shortening velocity were decreased at 1 minute but returned to control level by 3 minutes. Thus, although both left ventricular systolic and diastolic function were depressed by intracoronary administration of nifedipine, coronary sinus blood flow was augmented and remained increased long after changes in left ventricular contraction and relaxation had subsided. These temporal differences are consistent with animal studies showing a differential depressant effect of nifedipine on calcium uptake in smooth muscle and cardiac muscle.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6630785     DOI: 10.1016/s0735-1097(83)80341-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

1.  Protective effects of pretreatment with intracoronary nifedipine on myocardial ischemia and dysfunction.

Authors:  I Amende; G Herrmann; R Simon; W P Hood; P Wenzlaff; P R Lichtlen
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 2.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

3.  Intracellular calcium and ventricular function. Effects of nisoldipine on global ischemia in the isovolumic, coronary-perfused heart.

Authors:  I Amende; L A Bentivegna; A J Zeind; P Wenzlaff; W Grossman; J P Morgan
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

4.  Antiischemic effect of intracoronary diltiazem on myocardial ischemia during PTCA.

Authors:  K Saito; H Nonogi; Y Goto; A Itoh; S Daikoku; S Miyazaki; K Haze
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

5.  [Increase in liver circulation with nifedipine].

Authors:  J Nitsch; R Kuhnen; B Lüderitz
Journal:  Klin Wochenschr       Date:  1986-10-31

6.  Effect of nifedipine on the myocardial and vascular response to myocardial ischemia.

Authors:  D C Homans; E Sublett; X Z Dai; R J Bache
Journal:  Basic Res Cardiol       Date:  1986 Jul-Aug       Impact factor: 17.165

Review 7.  The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.

Authors:  A L Soward; G L Vanhaleweyk; P W Serruys
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

8.  Comparative study on the enhancement of ischemic tolerance by intracoronary pretreatment with three calcium antagonists in pig hearts.

Authors:  H H Klein; S Pich; S Lindert; K Nebendahl; H Kreuzer
Journal:  Cardiovasc Drugs Ther       Date:  1989-01       Impact factor: 3.727

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.